Andrew Grulich joins The Lancet HIV editor-in-chief Peter Hayward to discuss the EPIC-NSW study, looking at the population-level effectiveness of PrEP in New South Wales, Australia.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv